HCA targets 4-6% EBITDA, 8-12% EPS growth over 5 yrs; 2024 within ranges

HCA Healthcare, Inc.

Adjusted EBITDA growth target of 4% to 6% annually over next five years.
Diluted EPS growth target of 8% to 12% annually over next five years.
2024 expectations fall within those ranges, after resolving Q1 commercial payer dispute.
More detailed 2024 guidance to be provided in January year-end call.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.